Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis

doi:10.3748/wjg.v20.i23.7461

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 23

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4472)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

294

WORD

138

HTML

2455

Figures (1-2)

207

Tables (1-2)

200

Sum=3294

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

536

Download

642

Sum=1178

Jun 21, 2014 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Jun 21, 2014; 20(23): 7461-7465
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7461

Full Size Figure Download Figure

Figure 2 Positive expression of tissue factor pathway inhibitor in ulcerative colitis (A) and normal colon tissue (B). Magnification, × 400.

Citation: He HL, Zhang JB, Li Q. Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis. World J Gastroenterol 2014; 20(23): 7461-7465
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7461.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7461